Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 5 studies | 23% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 3% |
Insufficient scRNA-seq data for expression of EFS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2543.35 | 2607 / 2642 | 99% | 89.43 | 701 / 705 |
breast | 100% | 3146.89 | 458 / 459 | 88% | 36.90 | 985 / 1118 |
uterus | 100% | 5602.26 | 170 / 170 | 86% | 45.57 | 395 / 459 |
prostate | 100% | 4776.64 | 245 / 245 | 75% | 19.85 | 374 / 502 |
bladder | 100% | 3156.76 | 21 / 21 | 68% | 32.67 | 345 / 504 |
thymus | 99% | 2413.09 | 648 / 653 | 67% | 13.01 | 406 / 605 |
lung | 97% | 1572.34 | 563 / 578 | 68% | 28.60 | 786 / 1155 |
esophagus | 100% | 3537.84 | 1445 / 1445 | 58% | 34.79 | 107 / 183 |
ovary | 100% | 5150.00 | 180 / 180 | 52% | 14.69 | 224 / 430 |
skin | 94% | 5034.15 | 1693 / 1809 | 34% | 14.14 | 159 / 472 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.88 | 45 / 45 |
blood vessel | 100% | 3175.78 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2320.42 | 1201 / 1204 | 0% | 0 | 0 / 0 |
intestine | 83% | 2108.67 | 799 / 966 | 10% | 1.81 | 53 / 527 |
adrenal gland | 29% | 391.34 | 75 / 258 | 57% | 43.92 | 132 / 230 |
stomach | 62% | 1163.74 | 224 / 359 | 12% | 2.29 | 35 / 286 |
spleen | 74% | 836.77 | 179 / 241 | 0% | 0 | 0 / 0 |
kidney | 58% | 699.10 | 52 / 89 | 15% | 2.85 | 136 / 901 |
heart | 62% | 812.90 | 531 / 861 | 0% | 0 | 0 / 0 |
pancreas | 1% | 7.99 | 4 / 328 | 53% | 9.41 | 94 / 178 |
eye | 0% | 0 | 0 / 0 | 44% | 9.49 | 35 / 80 |
muscle | 5% | 46.96 | 41 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 9.60 | 2 / 226 | 2% | 0.28 | 8 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0007155 | Biological process | cell adhesion |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0016477 | Biological process | cell migration |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | EFS |
Protein name | Embryonal Fyn-associated substrate (hEFS) (Cas scaffolding protein family member 3) |
Synonyms | CASS3 |
Description | FUNCTION: Docking protein which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion. May serve as an activator of SRC and a downstream effector. Interacts with the SH3 domain of FYN and with CRK, SRC, and YES (By similarity). . |
Accessions | ENST00000216733.8 [O43281-1] ENST00000351354.3 [O43281-2] ENST00000429593.6 [O43281-3] O43281 |